Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Learn which type of credit card—cash back or points—provides more benefits based on your spending habits and preferences.
28,383 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
In the first half of 2026, Sandisk towered over the S&P 500. This article explains the drivers behind that outperform...
March's trading session brought a noticeable shift as airline stocks rallied amid easing fuel concerns. This piece br...
Retiring with $300,000 can work with smart budgeting, thoughtful withdrawals, and low-cost investing. This guide lays...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...
Analysts just boosted Crocs stock after recent upgrade rumors and data. This guide breaks down why the upgrade happen...
Netflix reports a strong Q1 2026, lifting free cash flow guidance and accelerating ad revenue. Analysts see a path to...
A billionaire’s online rant against a respected paper can ripple through markets and wallets. This article explains w...
A decade can dramatically change a portfolio. This article explores how you'd invested $10,000 Walmart ten years ago ...
As June approaches, Netflix stock may be on the radar for investors seeking a rebound. This article highlights three ...
The U.S. has removed foreign-access restrictions on Anthropic’s Claude 3.5 and Fable 5, signaling a renewed AI leader...
At a Miami conference this week, Tom Lee floated a $22,000 Ethereum target, tying it to a mix of Bitcoin price milest...